百晓学者学者目录

顾春艳

副教授、副研究员、教授、研究员,南京中医药大学

精选作品

期刊论文

2026

中药调控非编码RNA发挥抗肿瘤作用的研究进展

于添翼,张华夏,邓振东,顾春艳,杨烨

《南京中医药大学学报》

2026

宁夏枸杞子功效物质及药用价值的研究进展

纪吴子仪,何瑶,张劭哲,顾春艳

《南京中医药大学学报》

2026

逆转肿瘤治疗耐药——基于热休克蛋白90视角的机制与药物研发前沿

曹宇昊,孙善亮,顾春艳,杨烨

《药学进展》

2026

高负荷蛋白稳态:多发性骨髓瘤治疗的新兴靶点与研究进展

郭梦婕,唐校柱,顾春艳,杨烨

《药学学报》

2026

Xuanbi Xiaoliu formula alleviates bone destruction by targeting the CREBBP/c-Myc axis with saponarin in multiple myeloma

Jinjun Qian, Jiale Zhang, Zhendong Deng, 戈小洁, Cheng Wang, Shanliang Sun, Xichao Yu, Hongjie Wu, Xiangtu Kong, Jinrui Wei, Wenhao Yang, Xiaosu Feng, Song Ye, Chunyan Gu, Ye Yang, Haiwen Ni

Phytomedicine

2026

Correction: CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

Chunyan Gu, Wang Wang, Xiaozhu Tang, Tingting Xu, Yanxin Zhang, Mengjie Guo, Rongfang Wei, Yajun Wang, Artur Jurczyszyn, Siegfried Janz, Meral Beksaç, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Jingxuan Pan, Ye Yang

Molecular Cancer

2026

MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc

Zihao Liu, Tingting Hu, Jie Min, Chen Wang, Yuhao Cao, Mengjie Guo, Jinjun Qian, Chunyan Gu, Ye Yang

Experimental Hematology and Oncology

2026

Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling

C F Wang, Lingling Liu, J Y Zhang, Shanliang Sun, Xinyu Lv, Zihao Liu, Lianxin Zhou, Ziang Zhu, Haiwen Ni, Chunyan Gu, Ye Yang

Journal for ImmunoTherapy of Cancer

2026

NAT10‐Mediated ac4C Modification of circANKRD12 Reprograms the Tumor Microenvironment

J Y Zhang, Hui Shi, Chen Wang, Zihao Liu, Lianxin Zhou, Xinyu Lv, Mengjie Guo, Y F Yang, Chunyan Gu

Advanced Science

2026

CHD4 Orchestrates Chromatin Remodeling to Activate the c‐Myc Signaling Pathway in Cancer Pathogenesis

Pinggang Ding, Yuhao Cao, Zihao Liu, Jingru Xie, Lingling Liu, Shanliang Sun, Xichao Yu, Zhendong Deng, Zhimin Fan, Y F Yang, Chunyan Gu

MedComm – Oncology

2026

Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol‐Inspired Approach

Tianyi Yu, Cheng Wang, Jingru Xie, Yongxin Wei, Hongwei Cui, Huaxia Zhang, Fan Zhou, Zhendong Deng, Ya Yang, Chunyan Gu

Basic & Clinical Pharmacology & Toxicology

2026

Pharmacokinetic, Bioavailability, and Excretion Study of Cistanoside A Following Intragastric and Intravenous Administration in Rats Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.

Jing-Jing Sun, Yi-Fan Gu, Chunyan Gu, Wenjie Gu, Jia-Wei Shen

Biomedical chromotography

2025

中西医病理学融合教学路径探析

王岩,董银凤,王子妤,任宏艳,姚琦,张渤,顾春艳

《基础医学教育》

2025

人参皂苷Rg2调控PI3K/Akt通路逆转非小细胞肺癌顺铂耐药的分子机制研究

沈佳伟,顾春艳,褚菲菲,顾一帆,祁雯

《当代医药论丛》

2025

枸杞来源miR162a通过促进成骨分化发挥抗骨质疏松作用(英文)

顾春艳,余夕潮,唐校柱,龚蕾蕾,谭景全,张园娇,郑慧丽,王泽,张晨茜,朱业锦,周作建,虞鹤鸣,许凯,段金廒,顾晓松,杨烨

Engineering

2025

Guizhi Fuling capsules can alleviate bortezomib-induced peripheral neuropathy by decreasing Interleukin-6 levels to regulate mTOR pathway-induced autophagy

Jiaqi Fu, Qian Li, Runjie Sun, Chunyan Gu, Manya Yu, Wei Liu, Ye Yang, Xing Cui

Phytomedicine

2025

Targeting the Liquid–Liquid Separation Region of c‐Maf for Treating Chromosomal Translocations in Multiple Myeloma

Ze Wang, Mengjie Guo, Xichao Yu, Yi Sun, Haowen Bai, Lianxin Zhou, Zihao Liu, Hongming Huang, Chong Wang, Hong Liu, Chunyan Gu, Ye Yang

MedComm

2025

Extracellular vesicle-mediated delivery of circp53 suppresses the progression of multiple cancers by activating the CypD/TRAP/HSP90 pathway

Xichao Yu, Pinggang Ding, Mengjie Guo, Xiaozhu Tang, Ze Wang, Yuanjiao Zhang, Lianxin Zhou, Xinyu Lv, Hui Shi, Hongming Huang, Jialei Mao, Zhifeng Gu, Chunyan Gu, Yang Ye

Experimental & Molecular Medicine

2025

GART promotes multiple myeloma malignancy via tumor stemness mediated by activating the HSP90α/CDK6/β-catenin axis

Jinjun Qian, Han Meng, Ze Wang, Yi Sun, Xiao‐Ning Xu, Hui Shi, Cheng Wang, Lianxin Zhou, Xinyu Lv, Ye Yang, Chunyan Gu

European Journal of Pharmacology

2025

Bruceine A Inhibits Cell Proliferation by Targeting the USP13/PARP1 Signalling Pathway in Multiple Myeloma

Mengjie Guo, Han Meng, Yi Sun, Lianxin Zhou, Tingting Hu, Tianyi Yu, Haowen Bai, Yuanjiao Zhang, Chunyan Gu, Ye Yang

Basic & Clinical Pharmacology & Toxicology

2025

SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27

Ling Wang, Jie Min, Jinjun Qian, Xiaofang Huang, Xichao Yu, Yuhao Cao, Shan‐Liang Sun, Mengying Ke, Xinyu Lv, Wenfeng Su, Mengjie Guo, Nian‐Guang Li, Shiqian Qi, Hongming Huang, Chunyan Gu, Ye Yang

Acta Pharmaceutica Sinica B

2024

PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway

Zhendong Deng, Shan‐Liang Sun, Nian Zhou, Yumeng Peng, Long Cheng, Xichao Yu, Yuxia Yuan, Mengjie Guo, Min Xu, Yue-Xin Cheng, Fan Zhou, Nian‐Guang Li, Ye Yang, Chunyan Gu

Advanced Science

2024

CUL4A-DDB1-circRFWD2 E3 ligase complex mediates the ubiquitination of p27 to promote multiple myeloma proliferation

Jie Min, Jialei Mao, Hui Shi, Yumeng Peng, Xiao‐Ning Xu, Mengjie Guo, Xiaozhu Tang, Ye Yang, Chunyan Gu

Experimental Hematology and Oncology

2024

Exploring the landscape of post-translational modification in drug discovery

Yuhao Cao, Tianyi Yu, Ziang Zhu, Yuanjiao Zhang, Shan‐Liang Sun, Nian‐Guang Li, Chunyan Gu, Ye Yang

Pharmacology & Therapeutics

2024

Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects

Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, Junxian Lv, Chunyan Gu, Ye Yang

Journal of Experimental & Clinical Cancer Research

2024

FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway

Hongjie Wu, Jinjun Qian, Lianxin Zhou, Tingting Hu, Yuanjiao Zhang, Chen Wang, Ye Yang, Chunyan Gu

Aging

2024

Determination of Sennoside A in Rat Plasma by Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry and Its Application to a Rat Pharmacokinetic Study.

Jing-Jing Sun, Yifan Gu, Chunyan Gu, Wen Qi, Feifei Chu, Jia-Wei Shen

Biomedical chromotography

2023

基于ROS-NLRP3通路探讨麦粒灸治疗佐剂性关节炎大鼠的作用及机制

江彬,高梓珊,余芝,杨淑杰,张怡雯,李心成,白文欣,陈翀,穆艳云,顾春艳

《南京中医药大学学报》

2023

枸杞子功效物质的药理作用研究进展

唐校柱,闵捷,吕昕予,周作建,顾春艳,杨烨

《交通医学》

2023

病理生理学课程思政的实践路径探索

唐超,姚琦,王子妤,任宏艳,顾春艳,杨烨

《卫生职业教育》

2023

Lycium barbarum L.-Derived miR162a Functions on Osteoporosis Through Directly Promoting Osteoblast Formation

Chunyan Gu, Xichao Yu, Xiaozhu Tang, Leilei Gong, Jingquan Tan, Yuanjiao Zhang, Huili Zheng, Ze Wang, Chenqian Zhang, Yejin Zhu, Zuojian Zhou, Heming Yu, Kai Xu, Jin‐Ao Duan, Xiaosong Gu, Ye Yang

Engineering

2023

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation

Zigen Lin, Xiaozhu Tang, Yuhao Cao, Li-Jin Yang, Mingmei Jiang, Xinying Li, Jie Min, Bing Chen, Ye Yang, Chunyan Gu

Aging

2023

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation

Rongfang Wei, Yuhao Cao, Hongjie Wu, Xin Liu, Mingmei Jiang, Xian Luo, Zhendong Deng, Ze Wang, Mengying Ke, Yongqiang Zhu, Siqing Chen, Chunyan Gu, Ye Yang

Aging

2023

GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer

Chao Ke Tang, Mengying Ke, Xichao Yu, Shan‐Liang Sun, Xian Luo, Xin Liu, Yanyan Zhou, Ze Wang, Xing Cui, Chunyan Gu, Ye Yang

Advanced Science

2023

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

Chunyan Gu, Yajun Wang, Lulin Zhang, Qiao Li, Shan‐Liang Sun, Miaomiao Shao, Xiaozhu Tang, Pinggang Ding, Chao Tang, Yuhao Cao, Yanyan Zhou, Mengjie Guo, Rongfang Wei, Nian‐Guang Li, Yibei Xiao, Jin‐Ao Duan, Ye Yang

Journal of Experimental & Clinical Cancer Research

2023

Research progress on non-protein-targeted drugs for cancer therapy

Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Cheong Huang, Ye Yang

Journal of Experimental & Clinical Cancer Research

2023

Examining the evidence for exRNAs as communication molecules and emerging cancer biomarkers: a new therapeutic strategy

Xiaozhu Tang, Chunyan Gu, Ye Yang

ExRNA

2022

中医院校病理学课程思政的教学探索

王岩,赵玉男,王子妤,张璐瑶,姚琦,任宏艳,蒋凤荣,顾春艳

《卫生职业教育》

2022

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation

Zigen Lin, Xiaozhu Tang, Yuhao Cao, Li-Jin Yang, Mingmei Jiang, Xinying Li, Jie Min, Bing Chen, Ye Yang, Chunyan Gu

Aging

2022

G6PD promotes cell proliferation and dexamethasone resistance in multiple myeloma via increasing anti-oxidant production and activating Wnt/β-catenin pathway

Rui Li, Mengying Ke, Qi Mingming, Zhenru Han, Yuhao Cao, Zhendong Deng, Jinjun Qian, Ye Yang, Chunyan Gu

Experimental Hematology and Oncology

2022

DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway

Yanyan Zhou, Shaohua Huangfu, Muxi Li, Chao Tang, Jinjun Qian, Mengjie Guo, Zuojian Zhou, Ye Yang, Chunyan Gu

Aging

2022

Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation

Ying Chen, Jinjun Qian, Pinggang Ding, Wang Wang, Xinying Li, Xiaozhu Tang, Chao Tang, Ye Yang, Chunyan Gu

Cell Death and Disease

2022

AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation

Rongfang Wei, Yan Yu Zhu, Yuanjiao Zhang, Wene Zhao, Xichao Yu, Ling Wang, Chunyan Gu, Xiaosong Gu, Ye Yang

《癌症:英文版》

2022

NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway

Yuanjiao Zhang, Zhendong Deng, Shan‐Liang Sun, Siyuan Xie, Mingmei Jiang, Bing Chen, Chunyan Gu, Ye Yang

Frontiers in Oncology

2022

A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing

Xiaozhu Tang, Zhendong Deng, Pinggang Ding, Wanting Qiang, Yue Lu, Shengyao Gao, Ye Hu, Ye Yang, Juan Du, Chunyan Gu

Journal of Experimental & Clinical Cancer Research

2022

Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer

Hongbo Wang, Qinghai Meng, Jinjun Qian, Muxi Li, Chunyan Gu, Ye Yang

Pharmacology & Therapeutics

2022

Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication

Yuanjiao Zhang, Xichao Yu, Rongze Sun, Jie Min, Xiaozhu Tang, Zigen Lin, Siyuan Xie, Xinying Li, Sheng-Feng Lu, Zhidan Tian, Chunyan Gu, Lesheng Teng, Ye Yang

Clinical and Translational Medicine

2022

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma

Rongfang Wei, Xing Cui, Jie Min, Zigen Lin, Yanyan Zhou, Mengjie Guo, Xiaojuan An, Hao Liu, Siegfried Janz, Chunyan Gu, Hongbo Wang, Ye Yang

Acta Pharmaceutica Sinica B

2022

YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis

Zhen Hua, Rongfang Wei, Mengjie Guo, Zigen Lin, Xichao Yu, Xinying Li, Chunyan Gu, Ye Yang

Oncogene

2022

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

Chunyan Gu, Yajun Wang, Lulin Zhang, Qiao Li, Shan‐Liang Sun, Miaomiao Shao, Xiaozhu Tang, Pinggang Ding, Chao Tang, Yuhao Cao, Yanyan Zhou, Mengjie Guo, Rongfang Wei, Nian‐Guang Li, Yibei Xiao, Jin‐Ao Duan, Ye Yang

Journal of Experimental & Clinical Cancer Research

2021

Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine

Mengying Ke, Jinjun Qian, Feng Hao, Xinying Li, Hongjie Wu, Xian Fu Luo, Bin Xu, Chunyan Gu, Ye Yang

Frontiers in Oncology

2021

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability

Xiaozhu Tang, Mengjie Guo, Pinggang Ding, Zhendong Deng, Mengying Ke, Yuxia Yuan, Yanyan Zhou, Zigen Lin, Muxi Li, Chunyan Gu, Xiaosong Gu, Ye Yang

Signal Transduction and Targeted Therapy

2021

Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review)

Ling Wang, Jinjun Qian, Ye Yang, Chunyan Gu

International Journal of Oncology

2021

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

Ying Chen, Rui Qiang Li, Yuqi Zhu, Sixia Zhong, Jinjun Qian, Dongqing Yang, Artur J. Jurczyszyn, Meral Beksaç, Chunyan Gu, Ye Yang

Frontiers in Oncology

2021

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients

Mengying Ke, Liqing Kang, Ling Wang, Shu Yang, Yajun Wang, Haiyan Liu, Chunyan Gu, Hongming Huang, Ye Yang

Journal of Hematology & Oncology

2021

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

Chunyan Gu, Wang Wang, Xiaozhu Tang, Tingting Xu, Yanxin Zhang, Mengjie Guo, Rongfang Wei, Yajun Wang, Artur J. Jurczyszyn, Siegfried Janz, Meral Beksaç, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Jingxuan Pan, Ye Yang

Molecular Cancer

2021

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma

Mengjie Guo, Pinggang Ding, Zhen Yuan Zhu, Lu Fan, Yanyan Zhou, Shu Yang, Ye Yang, Chunyan Gu

Frontiers in Cell and Developmental Biology

2021

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

Fengjie Jiang, Xiaozhu Tang, Chao Tang, Zhen Hua, Mengying Ke, Chen Wang, Jiamin Zhao, Shengyao Gao, Artur J. Jurczyszyn, Siegfried Janz, Meral Beksaç, Fenghuang Zhan, Chunyan Gu, Ye Yang

Journal of Hematology & Oncology

2021

Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma

Renjie Dou, Jinjun Qian, Wei Wu, Yanxin Zhang, Yuxia Yuan, Mengjie Guo, Rongfang Wei, Yang Shu, Artur J. Jurczyszyn, Siegfried Janz, Meral Beksaç, Chunyan Gu, Ye Yang

Cell Death and Disease

2021

Alternative splicing and cancer: a systematic review

Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, Ye Yang

Signal Transduction and Targeted Therapy

2021

Review on circular RNAs and new insights into their roles in cancer

Xiaozhu Tang, Hongyan Ren, Mengjie Guo, Jinjun Qian, Ye Yang, Chunyan Gu

Computational and Structural Biotechnology Journal

2021

The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review).

Yuxia Yuan, Mengjie Guo, Chunyan Gu, Ye Yang

PubMed

2020

三维大体标本与数字化切片教学平台在中医院校病理学实验教学中的应用

郭梦婕,顾春艳

《中国中医药现代远程教育》

2020

基于混合学习的微课平台在中医药院校病理学教学中的应用

张宁,姚琦,张璐瑶,任宏艳,王荣根,赵玉男,顾春艳,戴建国,王子妤

《中国中医药现代远程教育》

2020

不同中药饮片在自动煎药机内吸水量的研究

顾一帆,顾春艳,顾雯洁,祁雯,沈佳伟

《上海医药》

2020

HUANGKUISIWUFANG inhibits pyruvate dehydrogenase to improve glomerular injury in anti-Thy1 nephritis model

Ting Lu, Yong Bian, Yan Zhu, Mengjie Guo, Ye Yang, Jianming Guo, Chunyan Gu, Jin‐Ao Duan

Journal of Ethnopharmacology

2020

CHEK1 and circCHEK1_246aa Promote Multiple Myeloma Malignancy By Evoking Chromosomal Instability and Bone Lesion

Ye Yang, Chunyan Gu, Wang Wang, Xiaozhu Tang

Blood

2020

RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma

Chunyan Gu, Ting Lu, Wang Wang, Miaomiao Shao, Rongfang Wei, Mengjie Guo, Rui Qiang Li, Li Qiao, Ye Hu, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Ye Yang

Leukemia

2020

Steroid 5α-Reductase Type I Induces Cell Viability and Migration via Nuclear Factor-κB/Vascular Endothelial Growth Factor Signaling Pathway in Colorectal Cancer

Rongfang Wei, Sixia Zhong, Li Qiao, Mengjie Guo, Miaomiao Shao, Suyu Wang, Bin Jiang, Ye Yang, Chunyan Gu

Frontiers in Oncology

2020

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

Ying Chen, Rui Li, Yuqi Zhu, Sixia Zhong, Jinjun Qian, Dongqing Yang, Artur J. Jurczyszyn, Meral Beksaç, Chunyan Gu, Ye Yang

Frontiers in Oncology

2020

Bioactive Compounds from Abelmoschus manihot L. Alleviate the Progression of Multiple Myeloma in Mouse Model and Improve Bone Marrow Microenvironment

Jianhao Hou, Jinjun Qian, Zhenlin Li, Aixiu Gong, Sixia Zhong, Qiao Li, Shihui Qian, Yanxin Zhang, Renjie Dou, Rui Li, Ye Yang, Chunyan Gu

OncoTargets and Therapy

2019

p70S6K1在结直肠癌中的作用及潜在分子机制(英文)

魏荣芳,郭梦婕,钱进军,杨烨,顾春艳

《南京中医药大学学报》

2019

The Efficacy of a Novel Oral Proteasome Inhibitor NNU546 in Multiple Myeloma

Ye Yang, Yongqiang Zhu, Chunyan Gu

Blood

2019

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

Chunyan Gu, Xuefang Jing, Carol Holman, Ramakrishna R. Sompallae, Fenghuang Zhan, Guido J. K. Tricot, Ye Yang, Siegfried Janz

BMC Cancer

2019

RFWD2 Induces Cellular Proliferation and Proteasome Inhibitor Resistance By Mediating p27 Ubiqutinaiton in Multiple Myeloma

Ye Yang, Mengjie Guo, Chunyan Gu

Blood

2019

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Mengjie Guo, Dongdong Sun, Zhimin Fan, Yuxia Yuan, Miaomiao Shao, Jianhao Hou, Yuqi Zhu, Rongfang Wei, Yan Zhu, Jinjun Qian, Fei Li, Ye Yang, Chunyan Gu

Frontiers in Oncology

2019

Lycium barbarum polysaccharides attenuate rat anti-Thy-1 glomerulonephritis through mediating pyruvate dehydrogenase

Ting Lu, Wen-e Zhao, Fang Zhang, Xiaohong Qi, Ye Yang, Chunyan Gu

Biomedicine & Pharmacotherapy

2019

Insights into a Crucial Role of TRIP13 in Human Cancer

Sizhao Lu, Jinjun Qian, Mengjie Guo, Chunyan Gu, Ye Yang

Computational and Structural Biotechnology Journal

2019

Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.

Sicheng Lu, Mengjie Guo, Zhimin Fan, Ying Chen, Xu-Qin Shi, Chunyan Gu, Ye Yang

PubMed

2019

Loquat leaf polysaccharides improve glomerular injury in rats with anti-Thy 1 nephritis via peroxisome proliferator-activated receptor alpha pathway.

Ting Lu, Zhimin Fan, Jianhao Hou, Xiaohong Qi, Mengjie Guo, Jianming Ju, Ye Yang, Chunyan Gu

PubMed

2019

BTK induces CAM-DR through regulation of CXCR4 degradation in multiple myeloma.

Wang Wang, Rongfang Wei, Shijia Liu, Li Qiao, Jianhao Hou, Chunyan Gu, Ye Yang

PubMed

2018

中药成分治疗糖尿病肾病的研究进展(英文)

王玲,李育,顾春艳

《南京中医药大学学报》

2018

基于THEOL平台病理学混合式教学在中医学专业中的应用

姚琦,张璐瑶,任宏艳,王子妤,赵玉男,蒋凤荣,戴建国,顾春艳

《中国中医药现代远程教育》

2018

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

Chunyan Gu, Xuefang Jing, Carol Holman, Ramakrishna R. Sompallae, Fenghuang Zhan, Guido J. K. Tricot, Ye Yang, Siegfried Janz

BMC Cancer

2018

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

Chunyan Gu, Carol Holman, Ramakrishna R. Sompallae, Xuefang Jing, Michael H. Tomasson, Dirk Hose, Anja Seckinger, Fenghuang Zhan, Guido J. K. Tricot, Hartmut Goldschmidt, Ye Yang, Siegfried Janz

Blood Cancer Journal

2017

苦瓜多糖的纯化、结构解析及其免疫调节和抗肿瘤活性研究(英文)

张逸,王旺,蔡寅,王旻,顾春艳,杨烨

《南京中医药大学学报》

2017

三黄汤加减治疗痰湿热结型多囊卵巢综合征临床观察

叶丽芳,邵鑫,刘苏,徐巍龙,阮园,邢莹,王林杰,顾春艳

《南京中医药大学学报》

2017

Chromosomal instability and acquired drug resistance in multiple myeloma

Wang Wang, Yi Zhang, Ruini Chen, Zhidan Tian, Yongpin Zhai, Siegfried Janz, Chunyan Gu, Ye Yang

Oncotarget

2017

BTK suppresses myeloma cellular senescence through activating AKT/P27/Rb signaling

Chunyan Gu, Hailin Peng, Yue Lu, Hongbao Yang, Zhidan Tian, Gang Yin, Wen Zhang, Sicheng Lu, Yi Zhang, Ye Yang

Oncotarget

2016

MK2 Is a Therapeutic Target for High-Risk Multiple Myeloma

Chunyan Gu, Hongbao Yang, Hailin Peng, Zhiye Xu, Ruini Chen, Ye Yang

Blood

2016

FOXM1, CDK6 and Rb Dependent Drug Resistance and Senescence in Myeloma

Chunyan Gu, Ruini Chen, Xuefang Jing, Siegfried Janz, Ye Yang

Blood

2016

An additive effect of anti-PAI-1 antibody to ACE inhibitor on slowing the progression of diabetic kidney disease

Chunyan Gu, Jiandong Zhang, Nancy A. Noble, Xiao-Rong Peng, Yufeng Huang

American Journal of Physiology-Renal Physiology

会议论文

2024

大学教学中科研思维培养的模式探索

王旺,王子妤,姚琦,董浩,顾春艳

《2023年中国陶行知研究会生活教育学术座谈会论文集(三)》

2018

基于数据挖掘和网络药理学探讨孙思邈治疗消渴病的遣方用药规律

邵鑫,冉颖卓,顾春艳,刘晶,方家,杨鑫,胡钢

《中华中医药学会糖尿病分会全国中医药糖尿病大会(第十九次)》

此主页由公开资料整理,尚未经学者本人认领。